Sable Bio

Sable Bio is a London-based drug-safety intelligence company building an AI-augmented platform, Sable Target Intelligence, that helps toxicologists, informaticians, and drug discovery scientists assess and mitigate target safety risk earlier in the drug development process. The platform aggregates and quantifies clinical, genetic, experimental, and literature evidence into a unified Target Safety Intelligence surface so safety teams can systematically prioritize and de-risk drug targets faster than traditional manual review. The company is headquartered in East London (Runway East Aldgate) and is backed by Episode One, Seedcamp, and MMC Ventures. Sable Bio was added to the API Evangelist network as a portfolio lead; as of this enrichment pass it operates a public marketing and product site with a Vanta-hosted trust center but does not yet publish a developer-facing API, documentation, or data-access surface.

Sable Bio is profiled on the APIs.io network. Tagged areas include Company, Drug Safety, Toxicology, Life Sciences, and Biotechnology.

Sable Bio’s developer surface includes engineering blog, signup flow, and 7 more developer resources.

🌐 Visit website 📡 Source on GitHub
19.5/100 emerging ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyDrug SafetyToxicologyLife SciencesBiotechnologyPharmaceuticalsDrug DiscoveryArtificial IntelligenceData Intelligence

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 19.5/100 · emerging
Contract Quality 0.0 / 25
Developer Ergonomics 0.4 / 20
Commercial Clarity 8.4 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/sable-bio: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 2

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Sable Bio Domain Security

TLSv1.3 · HSTS · DNSSEC · DMARC

SECURITY

Sable Bio Trust Center

trust center published

SECURITY

Resources

Get Started 1

Portal, sign-up, and the first successful call

SignUp
SignUp

Access & Security 2

Authentication, authorization, and security posture

TrustCenter
TrustCenter
 DomainSecurity
DomainSecurity

Commercial 2

Pricing, plans, and the legal terms of use

TermsOfService
TermsOfService
 PrivacyPolicy
PrivacyPolicy

Company 3

The organization behind the API

Website
Website
 Blog
Blog
 LinkedIn
LinkedIn

Other 1

Properties that don't map to a standard resource type

Product
Product

Source (apis.yml)

apis.yml Raw ↑ 
aid: sable-bio
name: Sable Bio
description: Sable Bio is a London-based drug-safety intelligence company building an AI-augmented platform, Sable Target
  Intelligence, that helps toxicologists, informaticians, and drug discovery scientists assess and mitigate target safety
  risk earlier in the drug development process. The platform aggregates and quantifies clinical, genetic, experimental, and
  literature evidence into a unified Target Safety Intelligence surface so safety teams can systematically prioritize and
  de-risk drug targets faster than traditional manual review. The company is headquartered in East London (Runway East Aldgate)
  and is backed by Episode One, Seedcamp, and MMC Ventures. Sable Bio was added to the API Evangelist network as a portfolio
  lead; as of this enrichment pass it operates a public marketing and product site with a Vanta-hosted trust center but does
  not yet publish a developer-facing API, documentation, or data-access surface.
url: https://raw.githubusercontent.com/api-evangelist/sable-bio/refs/heads/main/apis.yml
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://framerusercontent.com/assets/rtayjHLkJ6lU9Q3Qa3AAkKoNdDk.png
x-type: company
x-source: vc-portfolio
x-backed-by:
- seedcamp
- episode-one
- mmc-ventures
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-21'
tags:
- Company
- Drug Safety
- Toxicology
- Life Sciences
- Biotechnology
- Pharmaceuticals
- Drug Discovery
- Artificial Intelligence
- Data Intelligence
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
apis: []
common:
- type: Website
  url: https://sablebio.com/
- type: Product
  url: https://sablebio.com/product
- type: Blog
  url: https://sablebio.com/news
- type: SignUp
  url: https://sablebio.com/book-a-demo
- type: TermsOfService
  url: https://sablebio.com/documents/terms-of-use
- type: PrivacyPolicy
  url: https://sablebio.com/documents/privacy-policy
- type: TrustCenter
  url: security/sable-bio-trust-center.yml
- type: DomainSecurity
  url: security/sable-bio-domain-security.yml
- type: LinkedIn
  url: https://www.linkedin.com/company/sable-bio
x-enrichment:
  date: '2026-07-21'
  status: enriched
  artifacts_added: 2
  pass: local-v1